Physician profile
Mitchell Stelzer
NPI 1689035669
$36,542.34
in general payments reported to CMS, 2019-2025
20 companies · $8,660 in 2025
The $8,660 reported for 2025 was more than what 77% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,447 · 2020: $1,484 · 2021: $1,823 · 2022: $9,485 · 2023: $11K · 2024: $3,045 · 2025: $8,660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Food and Beverage: $11K · Education: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,492.42 |
| Food and Beverage | $10,574.59 |
| Education | $236.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13,211.45 | 2019-2025 | Farapulse, General - Therapies, Watchman Flx |
| Medtronic, INC. | $12,025.04 | 2022-2025 | Micra, Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan |
| Biosense Webster, INC. | $3,180.11 | 2021-2025 | Carto 3, Qdot Micro Catheter, Axert |
| Abbott Laboratories | $2,635.31 | 2021-2023 | Aveir, Gallant |
| Medical Device Business Services, INC. | $2,066.83 | 2022-2023 | Carto 3 |
| Amgen INC. | $1,007.78 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $637.06 | 2019-2021 | |
| Esperion Therapeutics, INC. | $251.17 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.10 | 2021-2022 | |
| Lantheus Medical Imaging, INC. | $207.84 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $189.16 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $176.23 | 2019-2020 | |
| Biotronik INC. | $169.42 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $149.09 | 2019-2022 | |
| Amarin Pharma, INC. | $125.48 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $113.17 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $53.86 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $48.85 | 2024 | Assure Wcd |
| Regeneron Healthcare Solutions, INC. | $32.21 | 2019-2020 | |
| Vifor Pharma, INC. | $30.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Stelzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.